Navigation Links
Envera Appoints Michael McErlean Fermentation Manager
Date:5/22/2013

West Chester, PA (PRWEB) May 22, 2013

Envera announced today that Michael McErlean has joined the company as Fermentation Manager. Mr. McErlean has an extensive background in cell production and served in a variety of leadership positions throughout his career.

Mike Matheny, President and Owner of Envera stated, “We are very pleased to have Mike join our team”. “Mike’s background is perfectly suited to oversee our newly installed large scale fermentation and downstream processing equipment”, added Matheny. “Mike’s hands on experience optimizing production protocols, establishing preventative maintenance procedures, and troubleshooting equipment is exactly what we need for this stage of Envera’s growth”, concluded Matheny.

Mr. McErlean holds a Bachelor’s Degree from Millersville University. Mike’s professional career includes 18 years of experience divided between Centocor, Merck Sharp & Dohme, and Fibrocell Science. During his time with these companies Mike gained hands on experience running a variety of bioreactors and downstream equipment as well as the implementation of new procedures and processes. Michael was also responsible for the generation of SOP’s, departmental logistics, and Quality/Regulatory issues.

“I am pleased to join a technology based company that is making a difference in the world”, stated McErlean. “Envera’s focus on using naturally occurring microorganisms to replace harsh chemicals, remediate environmental waste, and promote the growth and health of plants and animals was particularly appealing to me”, added Mike. “I am eager to utilize the newly installed fermentation and downstream processing equipment to support Envera’s expanding business”, finished McErlean.

Mr. McErlean will be located at Envera’s West Chester, Pennsylvania corporate offices and can be reached at 484-593-4002 or mmcerlean(at)envera(dot)com.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, waste water, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at mmatheny(at)envera(dot)com or phone 484-593-4002 for more information.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10752565.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Envera Increases Scientific Staff
2. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
3. Elsevier / MEDai Appoints Tom Zajac as New President
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
6. BioStorage Technologies Appoints New Member to Board of Directors
7. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
8. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
9. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
10. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
11. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... The research report by Transparency ... the  Global Label-Free Array Systems Market  accounted for a ... Players such as Biacore, Agilent Technologies, ForteBio, Molecular Devices ... global market due to their unmatched product portfolio and ... and timely product launches are expected to be the ...
(Date:12/9/2016)... India , December 9, 2016 According ... & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, ... Forecasts to 2021" published by MarketsandMarkets, the global market is expected ... in 2016, at a CAGR of 10.6% during the forecast period. ... ...
(Date:12/8/2016)... DIEGO, Dec. 8, 2016  OncoSec Medical Incorporated ... developing DNA-based intratumoral cancer immunotherapies, today announced financial ... "We are delivering on our commitment ... with ImmunoPulse® IL-12. We are pleased with the ... combination trial, and we are focused on advancing ...
(Date:12/8/2016)... 8, 2016  Renova™ Therapeutics, a biotechnology company ... and type 2 diabetes, announced that it has ... virus (AAV) vector developed in the laboratory of ... Stanford University. The company plans to use this ... product pipeline. "Early research has ...
Breaking Biology Technology:
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
Breaking Biology News(10 mins):